Predicting Global Fund grant disbursements for procurement of artemisinin-based combination therapies

被引：0
|
作者：
Justin M Cohen
Inder Singh
Megan E O'Brien
机构：
[1] Center for Strategic HIV Operations Research (CSHOR),Clinton Foundation HIV/AIDS Initiative
[2] Clinton Foundation HIV/AIDS Initiative,undefined
[3] Drug Access Team,undefined
来源：
Malaria Journal | / 7卷
关键词：
Malaria; Global Fund; Recipient Country; Discrete Disbursement; Funding Round;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Therapeutic response to four artemisinin-based combination therapies in Angola, 2021
    Dimbu, Pedro Rafael
    Labuda, Sarah
    Ferreira, Carolina Miguel
    Caquece, Felismina
    Andre, Kialanda
    Pembele, Garcia
    Pode, Dilunvuidi
    Joao, Maria Florinda
    Pelenda, Venceslau Mambi
    Andrade, Benjamin Nieto
    Horton, Breanna
    Kennedy, Culzean
    Svigel, Samaly S.
    Zhou, Zhiyong
    Morais, Joana F. M.
    do Rosario, Joana
    Fortes, Filomeno
    Martins, Jose Franco
    Plucinski, Mateusz M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (04)
  • [22] Artemisinin-based combination therapies: a vital tool in efforts to eliminate malaria
    Richard T. Eastman
    David A. Fidock
    Nature Reviews Microbiology, 2009, 7 : 864 - 874
  • [23] Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
    Nguyen, Tran Dang
    Gao, Bo
    Amaratunga, Chanaki
    Dhorda, Mehul
    Tran, Thu Nguyen-Anh
    White, Nicholas J.
    Dondorp, Arjen M.
    Boni, Maciej F.
    Aguas, Ricardo
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [24] "Misstatements in Artemisinin-Based Combination Therapies in Malaria Treatment" by Fleckenstein and Miller
    Maldonado, Joyce Hernandez
    Grundmann, Oliver
    JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 62 (10): : 1323 - 1324
  • [25] Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
    Tran Dang Nguyen
    Bo Gao
    Chanaki Amaratunga
    Mehul Dhorda
    Thu Nguyen-Anh Tran
    Nicholas J. White
    Arjen M. Dondorp
    Maciej F. Boni
    Ricardo Aguas
    Nature Communications, 14
  • [26] Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
    Solange Youdom Whegang
    Rachida Tahar
    Vincent Ngane Foumane
    Georges Soula
    Henri Gwét
    Jean-Christophe Thalabard
    Leonardo K Basco
    Malaria Journal, 9
  • [27] Efficacy of non-artemisinin- and artemisinin-based combination therapies for uncomplicated falciparum malaria in Cameroon
    Whegang, Solange Youdom
    Tahar, Rachida
    Foumane, Vincent Ngane
    Soula, Georges
    Gwet, Henri
    Thalabard, Jean-Christophe
    Basco, Leonardo K.
    MALARIA JOURNAL, 2010, 9
  • [28] Artemisinin resistance or artemisinin-based combination therapy resistance?
    Wongsrichanalai, Chansuda
    LANCET INFECTIOUS DISEASES, 2013, 13 (02): : 114 - 115
  • [29] Safety of Artemisinin-Based Combination Therapies in Nigeria: A Cohort Event Monitoring Study
    Peter Usman Bassi
    Adeline I. Osakwe
    Ambrose Isah
    Comfort Suku
    Musa Kalat
    Iliya Jalo
    Robinson Daniel Wammanda
    Chika Ugochukwu
    Olubukula Adesina
    Eno Etim Nyong
    Frank Osungwu
    Shanti Pal
    Sylvester Chigozie Nwoasu
    Magnus Wallberg
    David Coulter
    Drug Safety, 2013, 36 : 747 - 756
  • [30] A major transition in malaria treatment: The adoption and deployment of artemisinin-based combination therapies
    Bosman, Andrea
    Mendis, Kamini N.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2007, 77 (06): : 193 - 197
12345